Osteopontin – a biomarker of disease, but also of stage stratification of the functional myocardial contractile deficit by chronic ischaemic heart disease

References

• López B, González A, Lindner D, et al. Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase? Cardiovasc Res 2013;99:111–20.
   PubMed Web of Science ®Google Scholar
• Graf K, Do YS, Ashizawa N, et al. Myocardial osteopontin expression is associated with left ventricular hypertrophy. Circulation 1997;96:3063–71.
   PubMed Web of Science ®Google Scholar
• Lorenzen JM, Schauerte C, Hübner A, et al. Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis. Eur Heart J 2015;36:2184–96.
   PubMed Web of Science ®Google Scholar
• Stawowy P, Blaschke F, Pfautsch P, et al. Increased myocardial expression of osteopontin in patients with advanced heart failure. Eur J Heart Fail 2002;4:139–46.
   PubMed Web of Science ®Google Scholar
• Rosenberg M, Zugck C, Nelles M, et al. Osteopontin, a new prognostic biomarker in patients with chronic heart failure. Circ Heart Fail 2008;1:43–9.
   PubMed Web of Science ®Google Scholar
• Okamoto H. Osteopontin and cardiovascular system. Mol Cell Biochem 2007;300:1–7.
   PubMed Web of Science ®Google Scholar
• Lindsey ML, Zouein FA, Tian Y, et al. Osteopontin is proteolytically processed by matrix metalloproteinase 9. Can J Physiol Pharmacol 2015;93:879–86.
   PubMed Web of Science ®Google Scholar
• Wu LZ, Liu XL, Xie QZ. Osteopontin facilitates invasion in human trophoblastic cells via promoting matrix metalloproteinase-9 in vitro. Int J Clin Exp Pathol 2015;8:14121–30.
   PubMed Web of Science ®Google Scholar
• Israeli-Rosenberg S, Manso AM, Okada H, Ross RS. Integrins and integrin-associated proteins in the cardiac myocyte. Circ Res 2014;114:572–86.
   PubMed Web of Science ®Google Scholar
• Lodish H, Berk A, Matsudaira P, et al. Molecular cell biology. 5th ed. New York: W. H. Freeman; 2003.
   Google Scholar
• Coculescu BI, Dincă GV, Bălăeţ C, et al. Myeloperoxidase, a possible biomarker for the early diagnosis of cardiac diastolic dysfunction with preserved ejection fraction. J Enzyme Inhib Med Chem 2018;33:1292–8.
   PubMed Web of Science ®Google Scholar
• Matsui Y, Jia N, Okamoto H, et al. Role of osteopontin in cardiac fibrosis and remodelling in angiotensin II induced cardiac hypertrophy. Hypertension 2004;43:1195–201.
   PubMed Web of Science ®Google Scholar
• Denhardt DT, Noda M, O’Regan AW, et al. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001;107:1055–61.
   PubMed Web of Science ®Google Scholar
• Singh M, Dalal S, Singh K. Osteopontin: at the cross-roads of myocyte survival and myocardial function. Life Sci 2014;118:1–6.
   PubMed Web of Science ®Google Scholar
• Kotlyar E, Vita JA, Winter MR, et al. The relationship between aldosterone, oxidative stress, and inflammation in chronic, stable human heart failure. J Card Fail 2006;12:122–7.
   PubMed Web of Science ®Google Scholar
• Schipper ME, Scheenstra MR, van Kuik J, et al. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support. J Heart Lung Transplant 2011;30:805–10.
   PubMed Web of Science ®Google Scholar
• von Haehling S, Anker SD, Bassenge E. Statins and the role of nitric oxide in chronic heart failure. Heart Fail Rev 2003;8:99–106.
   PubMed Web of Science ®Google Scholar
• Singh M, Foster CR, Dalal S, Singh K. Osteopontin: role in extracellular matrix deposition and myocardial remodeling post-MI. J Mol Cell Cardiol 2010;48:538–43.
   PubMed Web of Science ®Google Scholar
• Satoh M, Nakamura M, Akatsu T, et al. Myocardial osteopontin expression is associated with collagen fibrillogenesis in human dilated cardiomyopathy. Eur J Heart Fail 2005;7:755–62.
   PubMed Web of Science ®Google Scholar
• Zhao X, Johnson JN, Singh K, Singh M. Impairment of myocardial angiogenic response in the absence of osteopontin. Microcirculation 2007;14:233–40.
   PubMed Web of Science ®Google Scholar
• Coculescu BI, Dincă GV, Manole G, et al. Serum concentration of hsCRP – possible marker for therapy evaluation in left ventricular dysfunction with preserved ejection fraction. Rev Chim (Bucharest) 2018;69:2885–90.
   Web of Science ®Google Scholar
• Bodh IJ. The role of nitric oxide in heart failure. Boston (USA): Kluwer Academic Publishers; 2004.
   Google Scholar
• Bălăeț C, Coculescu BI, Bălăeț M, et al. Haemolytic anaemia and hepatocitolysis associated with hypermagnesaemia by repeated exposures to copper-calcium fungicides. J Enzyme Inhib Med Chem 2018;33:184–9.
   PubMed Web of Science ®Google Scholar
• Tousoulis D, Oikonomou E, Economou EK, et al. Inflammatory cytokines in atherosclerosis: current therapeutic approaches. Eur Heart J 2016;37:1723–32.
   PubMed Web of Science ®Google Scholar
• Ridker PM. From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection. Circ Res 2016;118:145–56.
   PubMed Web of Science ®Google Scholar
• Aukrust P, Damås JK, Gullestad L. Immunomodulating therapy: new treatment modality in congestive heart failure. Congest Heart Fail 2003;9:64–9.
   PubMedGoogle Scholar
• Dick SA, Epelman S. Chronic heart failure and inflammation: what do we really know? Circ Res 2016;119:159–76.
   PubMed Web of Science ®Google Scholar
• Bălăeț C, Coculescu BI, Manole G, et al. Gamma-glutamyltransferase, possible novel biomarker in colon diverticulosis: a case-control study. J Enzyme Inhib Med Chem 2018;33:428–32.
   PubMed Web of Science ®Google Scholar
• Miao L, St Clair DK. Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med 2009;47:344–56.
   PubMed Web of Science ®Google Scholar
• Available from: https://geomarz.wordpress.com/2010/05/28/disfunctia-microcirculatiei-si-ros-continuare-8/ [last accessed 18 Dec 2018] [in Romanian].
   Google Scholar
• Li J, Yousefi K, Ding W, et al. Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure. Cardiovasc Res 2017;113:633–43.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy P, Peterson JT, Subramanian V, et al. Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction. Mol Cell Biochem 2009;322:53–62.
   PubMed Web of Science ®Google Scholar
• Xie Z, Singh M, Singh K. Osteopontin modulates myocardial hypertrophy in response to chronic pressure overload in mice. Hypertension 2004;44:826–31.
   PubMed Web of Science ®Google Scholar
• Cabiati M, Svezia B, Matteucci M, et al. Myocardial expression analysis of osteopontin and its splice variants in patients affected by end-stage idiopathic or ischemic dilated cardiomyopathy. PLoS One 2016;11:e0160110.
   PubMed Web of Science ®Google Scholar
• Lenga Y, Koh A, Perera AS, et al. Osteopontin expression is required for myofibroblast differentiation. Circ Res 2008;102:319–27.
   PubMed Web of Science ®Google Scholar
• Del Ry S, Giannessi D, Maltinti M, et al. Increased plasma levels of osteopontin are associated with activation of the renin–aldosterone system and with myocardial and coronary microvascular damage in dilated cardiomyopathy. Cytokine 2010;49:325–30.
   PubMed Web of Science ®Google Scholar
• Zahradka P. Novel role for osteopontin in cardiac fibrosis. Circ Res 2008;102:270–2.
   PubMed Web of Science ®Google Scholar
• An Z, Yang G, Zheng H, et al. Biomarkers in patients with myocardial fibrosis. Open Life Sci 2017;12:337–44.
   Web of Science ®Google Scholar
• Niţă D, Gurzun M, Chiriac L, et al. Impact of stent diameter and length on in-stent restenosis after bare metal stent implantation. Rom Biotechnol Lett 2017;22:12347–51.
   Web of Science ®Google Scholar
• Ferrario CM, Schiffrin EL. Translational success stories: role of mineralocorticoid receptor antagonists in cardiovascular disease. Circ Res 2015;116:206–13.
   PubMed Web of Science ®Google Scholar
• Maisel AS, Bhalla V, Braunwald E. Cardiac biomarkers: a contemporary status report. Nat Clin Pract Cardiovasc Med 2006;3:24–34.
   PubMedGoogle Scholar